Ondine Congratulates Dr. Bryon Bhagwandin For Presenting His Research At The International AIDS Society Conference 2011

The use of Photodisinfection to disinfect the birth canal is a novel approach that can bypass the stigma associated with HIV treatment and any reliance on patient compliance.

Ondine is pleased to congratulate Dr. Bryon Bhagwandin of Vitalwave™ on the publication of his abstract at the International AIDS Society (IAS) Conference. This is an important accomplishment as it highlights the need to develop new approaches in preventing mother-to-child HIV transmission.

A higher vaginal HIV viral load has been independently associated with a higher risk of transmission. Dr. Bhagwandin’s study evaluated the use of antimicrobial Photodynamic Therapy (aPDT), also known as Photodisinfection, as a means to reduce the vaginal viral load of pregnant women infected with HIV/AIDS. In 2008, more than 1.4 million pregnant women were living with this disease. An additional 430,000 children had been infected through mother-to-child transmission.

More than 90% of children living with HIV in developing countries were infected through their mothers, and many are left without regular access to effective prophylaxis such as antiretroviral medication. Innovative approaches are therefore needed to address this problem. Vitalwave™ is the application of antimicrobial Photodynamic Therapy to the birth canal and is designed to destroy a variety of pathogens, including HIV. Currently under development, Vitalwave will be an in-clinic, low cost, and easy to administer procedure for use in the third world.

“The Use of Antimicrobial Photodynamic Therapy for Prevention of HIV Transmission from Mother–to-Child: A Novel Approach” was presented at the International Aids Society (IAS) 6th Conference on HIV Pathogenesis, Treatment & Prevention which will took place in Rome, Italy from July 17th-20th.

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Staypressed theme by Themocracy